travocort has been researched along with miconazole in 21 studies
| Studies (travocort) | Trials (travocort) | Recent Studies (post-2010) (travocort) | Studies (miconazole) | Trials (miconazole) | Recent Studies (post-2010) (miconazole) |
|---|---|---|---|---|---|
| 21 | 2 | 5 | 2,309 | 238 | 476 |
| Protein | Taxonomy | travocort (IC50) | miconazole (IC50) |
|---|---|---|---|
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | 6.5 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.4 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 5.314 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cytochrome P450 1A2 | Mus musculus (house mouse) | 4.55 | |
| Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | 4.55 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 4.55 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.16 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.8 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.939 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 4.336 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.197 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.4938 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.966 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.811 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.32 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.971 | |
| Aromatase | Homo sapiens (human) | 0.6 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.2 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 5.482 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 3.7 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 7.089 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.598 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.154 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 7.8 | |
| Substance-K receptor | Homo sapiens (human) | 4.839 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 6.247 | |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.8 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.939 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.263 | |
| Histamine H2 receptor | Homo sapiens (human) | 6.75 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.046 | |
| Substance-P receptor | Homo sapiens (human) | 6.813 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.907 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 5.314 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.778 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
| Mu-type opioid receptor | Homo sapiens (human) | 6.059 | |
| D(3) dopamine receptor | Homo sapiens (human) | 3.199 | |
| Delta-type opioid receptor | Homo sapiens (human) | 3.387 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 6.594 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 5.545 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Cholinesterase | Equus caballus (horse) | 5.55 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.701 | |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.2 | |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 13 (61.90) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gip, L; Langen, ML | 1 |
| Langen, ML; Nolting, S | 1 |
| Glad'ko, VV; Trubin, AB; Volkova, OA | 1 |
| Czaika, VA | 1 |
| Friedrich, M; Havlickova, B | 1 |
| Onsun, N; Pirmit, S; Ummetoglu, O | 1 |
| Kotrekhova, LP | 1 |
| Jürgens, J | 2 |
| Kim, WS; Lee, GY | 1 |
| Ghislanzoni, M | 1 |
| Dogan, B; Karabudak, O | 1 |
| Valenti, L | 1 |
| Tietz, HJ | 1 |
| Kye, YC | 1 |
| Olkhovskaya, KB; Perlamutrov, Y | 1 |
| Veraldi, S | 3 |
| Piergiorgio, M | 1 |
| Antonelli, E; Bellini, V; Bianchi, L; Hansel, K; Stingeni, L | 1 |
2 review(s) available for travocort and miconazole
| Article | Year |
|---|---|
The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Child; Child, Preschool; Dermatomycoses; Diflucortolone; Double-Blind Method; Drug Combinations; Humans; Inflammation; Miconazole; Randomized Controlled Trials as Topic; Tinea; Treatment Outcome | 2008 |
Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Coinfection; Dermatomycoses; Diflucortolone; Drug Combinations; Gram-Positive Bacterial Infections; Humans; Medication Adherence; Miconazole; Skin Diseases, Bacterial; Treatment Outcome | 2013 |
2 trial(s) available for travocort and miconazole
| Article | Year |
|---|---|
[Results of a contralateral comparative study between Travocort cream and Travogen cream in inflammatory and allergic dermatomycoses (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dermatomycoses; Diflucortolone; Double-Blind Method; Drug Combinations; Female; Fluocortolone; Humans; Hypersensitivity; Imidazoles; Inflammation; Male; Miconazole; Middle Aged | 1980 |
[Are topical corticoids advantageous and justifiable in the treatment of dermatomycoses? (Travocort cream and Travogen cream were compared in 100 patients in an interindividual double-blind trial) (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dermatomycoses; Diflucortolone; Double-Blind Method; Drug Combinations; Female; Fluocortolone; Humans; Imidazoles; Male; Miconazole; Middle Aged; Ointments | 1980 |
17 other study(ies) available for travocort and miconazole
| Article | Year |
|---|---|
[The efficacy of Travogen and Travocort in treating dermatomycoses].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Dermatomycoses; Diflucortolone; Drug Combinations; Drug Evaluation; Female; Humans; Male; Miconazole; Middle Aged; Ointments; Time Factors | 1997 |
Superficial dermatomycoses worldwide: multinational treatment experience with a combination of isoconazole nitrate and diflucortolone valerate. Introduction.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Dermatomycoses; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Global Health; Humans; Internationality; Miconazole; Tinea; Treatment Outcome | 2008 |
Successful therapy of tinea cruris with topical isoconazole in combination with a corticosteroid.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Groin; Humans; Male; Miconazole; Skin; Tinea; Treatment Outcome | 2008 |
The effective use of isoconazole nitrate and diflucortolone valerate cream in the treatment of inguino-femoral skin fold mycosis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Groin; Humans; Male; Miconazole; Middle Aged; Ointments; Skin; Tinea; Treatment Outcome; Trichophyton | 2008 |
Tinea cruris treated with a combined topical therapy containing isoconazole and a corticosteroid.
Topics: Aged; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Groin; Humans; Male; Miconazole; Ointments; Skin; Tinea; Treatment Outcome | 2008 |
Tinea corporis of the shin and chest successfully treated with a topical antifungal and corticosteroid cream.
Topics: Administration, Cutaneous; Aged; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Humans; Leg; Male; Miconazole; Ointments; Skin; Thorax; Tinea; Treatment Outcome; Trichophyton | 2008 |
Tinea corporis treated with a combined topical therapy containing isoconazole and a corticosteroid.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Back; Child; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Miconazole; Ointments; Skin; Tinea; Treatment Outcome; Trichophyton | 2008 |
Tinea incognito due to Trichophyton rubrum responsive to topical therapy with isoconazole plus corticosteroid cream.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Foot Dermatoses; Humans; Leg; Male; Miconazole; Ointments; Onychomycosis; Skin; Tinea; Treatment Outcome; Trichophyton | 2008 |
Treatment of candidal intertrigo with a topical combination of isoconazole nitrate and diflucortolone valerate.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Antifungal Agents; Breast; Candida; Candidiasis, Cutaneous; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imidazoles; Intertrigo; Miconazole; Ointments; Skin; Treatment Outcome | 2008 |
Topical treatment of intertriginous candidal infection.
Topics: Aged; Anti-Inflammatory Agents; Antifungal Agents; Axilla; Candida; Candidiasis, Cutaneous; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Humans; Intertrigo; Male; Miconazole; Ointments; Skin; Treatment Outcome | 2008 |
Balanitis with eczematous perigenital intertriginous candidosis.
Topics: Adult; Anti-Inflammatory Agents; Antifungal Agents; Balanitis; Candida albicans; Candidiasis, Cutaneous; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Eczema; Genitalia, Male; Humans; Intertrigo; Male; Miconazole; Ointments; Treatment Outcome | 2008 |
Successful treatment of tinea pedis with a topical agent containing isoconazole nitrate and diflucortolone valerate.
Topics: Adult; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Drug Therapy, Combination; Humans; Male; Miconazole; Ointments; Skin; Tinea Pedis; Toes; Treatment Outcome | 2008 |
Step-wise treatment of athlete's foot (tinea pedis) using isoconazole combined with a corticosteroid followed by isoconazole alone.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Foot; Humans; Male; Miconazole; Ointments; Skin; Tinea Pedis; Treatment Outcome | 2008 |
The benefits of combination therapy in dermatomycoses.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Coinfection; Dermatomycoses; Diflucortolone; Drug Combinations; Humans; Miconazole; Skin Diseases, Bacterial; Treatment Outcome | 2013 |
Effective treatment of erythrasma-associated inflammation and pruritus with isoconazole nitrate and diflucortolone valerate combination therapy.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Antifungal Agents; Diflucortolone; Drug Combinations; Erythrasma; Female; Humans; Inflammation; Miconazole; Pruritus; Thigh; Treatment Outcome | 2013 |
Rapid relief of intertrigo-associated pruritus due to Candida albicans with isoconazole nitrate and diflucortolone valerate combination therapy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antifungal Agents; Candida albicans; Candidiasis; Diflucortolone; Drug Combinations; Humans; Intertrigo; Male; Miconazole; Pruritus; Treatment Outcome | 2013 |
Contact allergy to isoconazole nitrate with unusual spreading over extensive regions.
Topics: Aged; Antifungal Agents; Dermatitis, Allergic Contact; Diflucortolone; Drug Combinations; Drug Eruptions; Female; Humans; Miconazole; Tinea | 2017 |